v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash Flows From Operating Activities              
Net loss $ (307,397) $ (590,489) $ (649,418) $ (587,259) $ (897,886) $ (1,236,677)  
Non-cash items:              
Stock-based compensation expense 24,782   250,189   234,798 482,122  
Depreciation expense         56  
Amortization of ROU asset         1,284 1,281  
Expenses allocated by Sanovas on behalf of Company         330,750 330,750  
Changes in operating liabilities:              
Increase in accounts payable and accrued liabilities         84,198 94,602  
Decrease in lease liability         (948) (348)  
Increase in accrued interest         1,920 1,920  
Total adjustments         652,002 910,383  
Net cash (used in) operating activities         (245,884) (326,294)  
Cash Flows From Financing Activities              
Proceeds from collection of stock subscription receivable         125,000 150,000  
Proceeds from sale of common stock         200,000 86,000  
Advances from related parties, net         (66,658) 85,073  
Net cash provided by financing activities         258,342 321,073  
Net (decrease) in cash         12,458 (5,221)  
Cash at beginning of period   $ 14,774   $ 6,060 14,774 6,060 $ 6,060
Cash at end of period $ 27,232   $ 839   27,232 839 $ 14,774
Supplemental Disclosure of Cash Flow information:              
Interest paid during the period          
Income taxes paid during the period